Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors

被引：0

作者：

机构：

来源：

Journal of Acupuncture and Tuina Science | 2011年 / 9卷 / 04期

关键词：

LUTS; Epidemiology and Risk Factors; BPH; Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms;

D O I：

暂无

中图分类号：

R697 [男性生殖器疾病];

学科分类号：

1002 ; 100210 ;

摘要：

The epidemiology of benign prostatic hyperplasia(BPH)and male lower urinary tract symptoms(LUTS)has evolved considerably during the past several years.The term LUTS describes a distinct phenotype and allows for a broad epidemiologic description of urinary symptoms at a population level.Although it is becoming the preferred term for studying urinary symptoms in populations,LUTS

引用

页码：244 / 244

页数：1

共 50 条

[31] Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Gacci, Mauro
Eardley, Ian
Giuliano, Francois
Hatzichristou, Dimitris
Kaplan, Steven A.
Maggi, Mario
McVary, Kevin T.
Mirone, Vincenzo
Porst, Hartmut
Roehrborn, Claus G.
EUROPEAN UROLOGY, 2011, 60 (04) : 809 - 825
[32] Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms
St Sauver, Jennifer L.
Jacobsen, Steven J.
Jacobson, Debra J.
McGree, Michaela E.
Girman, Cynthia J.
Nehra, Ajay
Roger, Veronique L.
Lieber, Michael M.
BJU INTERNATIONAL, 2011, 107 (03) : 443 - 450
[33] Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention
Nickel, J. Curtis
Roehrborn, Claus G.
Castro-Santamaria, Ramiro
Freedland, Stephen J.
Moreira, Daniel M.
JOURNAL OF UROLOGY, 2016, 196 (05) : 1493 - 1498
[34] PROSTATIC ARTERY EMBOLIZATION AS A NEW OPTION IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN BENIGN PROSTATIC HYPERPLASIA - CURRENT EVIDENCE
Novosel, Luka
Pezelj, Ivan
Tomaskovic, Igor
Zadravec, Dijana
Ruzic, Boris
ACTA CLINICA CROATICA, 2018, 57 : 66 - 70
[35] Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia
Griwan, Mahavir Singh
Karthikeyan, Y. R.
Kumar, Mandeep
Singh, Bikram Jit
Singh, Santosh Kumar
UROLOGY ANNALS, 2014, 6 (03) : 181 - 186
[36] Role of calcium channel blockers in lower urinary tract symptoms in benign prostatic hyperplasia: a literature review
Iheanacho, Chinonyerem O.
Okwesilieze, Chikezie N.
Eyong, Abiodun K.
AFRICAN JOURNAL OF UROLOGY, 2022, 28 (01)
[37] Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction
Silva, Valter
Grande, Antonio Jose
Peccin, Maria S.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (04):
[38] Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta-Analysis
Gacci, Mauro
Ficarra, Vincenzo
Sebastianelli, Arcangelo
Corona, Giovanni
Serni, Sergio
Shariat, Shahrokh F.
Maggi, Mario
Zattoni, Filiberto
Carini, Marco
Novara, Giacomo
JOURNAL OF SEXUAL MEDICINE, 2014, 11 (06) : 1554 - 1566
[39] Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?
Roumeguere, Thierry
Boudjeltia, K. Zouaoui
Hauzeur, Claude
Schulman, Claude
Vanhaeverbeek, Michel
Wespes, Eric
BJU INTERNATIONAL, 2009, 104 (04) : 511 - 517
[40] Lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction: from physiology to clinical aspects
Calogero, Aldo E.
Burgio, Giovanni
Condorelli, Rosita A.
Cannarella, Rossella
La Vignera, Sandro
AGING MALE, 2018, 21 (04) : 261 - 271

← 1 2 3 4 5 →